Formed in 2017, LifeSci Venture Partners is the early stage investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy formed in 2010.
Our investment principals have broad-ranging life sciences experience including public and private investing, deal structuring, investment banking, equity capital markets, equity research, and bench research - both basic science and applied.
Across our affiliated business units, we employ more than 120 experienced investment and science professionals, including 20+ PhDs and MDs in New York City, Boston, Philadelphia, London, Geneva, Paris and Tel Aviv. We make the broad resources and expertise of our team available to our portfolio companies in helping them execute on their business plans and maximize shareholder value.
Location: United States, New York
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 15
| Date | Name | Website | Total Raised | Location |
| 21.08.2020 | Science 37 | science37.... | $135.5M | United Sta... |
| - | Novus Ther... | novusthera... | - | - |
| - | Attune Pha... | attunephar... | $23M | - |
| - | Metacrine | metacrine.... | $123M | United Sta... |
| - | Orasis | orasis-pha... | $43M | - |
| - | Athira Pha... | athira.com | $289M | United Sta... |
| - | Allakos In... | allakos.co... | $292M | United Sta... |
| - | Rocket Pha... | rocketphar... | - | United Sta... |
| - | Biolinq | biolinq.me | $14.75M | United Sta... |
| - | Beta Bioni... | betabionic... | $220M | United Sta... |
Show more
News 19
Show more